Amy Wang, PhD, MBA, is the Chief Executive Officer of Enspire Bio. Her role is to work with the UCLA collaborators and scientific founders to ensure each project moves toward translational development to be clinically relevant. As an entrepreneur and merchant banker, Dr. Wang is focused on life science technologies and therapeutics. Dr. Wang is a co-founder of Pulse Bioscience (NASDAQ: PLSE) and Cue Biopharma (NASDAQ: CUE). She also served as a Board Member and early investor in cell-free liquid biopsy company Liquid Genomics (acquired by NantCell).  Prior to her investment banking role, Dr. Wang began her career 15 years ago as a scientist at type 1 diabetes company Amcyte, Inc. (acquired by ReNeuron) and Life Technologies (acquired by ThermoFisher Scientific). Dr. Wang received her B.S. in the Department of Chemistry and Biochemistry and Ph.D. in Biological Chemistry at University of California, Los Angeles and holds an MBA from UCLA Anderson School of Management.